Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


09.04.2018

1 Acta Neuropathol
1 AJNR Am J Neuroradiol
3 BMC Cancer
1 Cancer Res
1 Clin Cancer Res
1 Eur J Cancer
1 Int J Radiat Oncol Biol Phys
3 J Neurooncol
2 J Neurosurg
3 Neuro Oncol
5 Neurosurgery
1 PLoS Genet
2 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. BARTHEL FP, Wesseling P, Verhaak RGW
    Reconstructing the molecular life history of gliomas.
    Acta Neuropathol. 2018 Apr 3. pii: 10.1007/s00401-018-1842.
    PubMed     Text format     Abstract available


    AJNR Am J Neuroradiol

  2. BAHRAMI N, Piccioni D, Karunamuni R, Chang YH, et al
    Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab.
    AJNR Am J Neuroradiol. 2018 Apr 5. pii: ajnr.A5620. doi: 10.3174/ajnr.A5620.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. BOTTCHER MA, Held-Feindt J, Synowitz M, Lucius R, et al
    Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation.
    BMC Cancer. 2018;18:376.
    PubMed     Text format     Abstract available

  4. FATAI AA, Gamieldien J
    A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    BMC Cancer. 2018;18:377.
    PubMed     Text format     Abstract available

  5. CHIO CC, Chen KY, Chang CK, Chuang JY, et al
    Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    BMC Cancer. 2018;18:379.
    PubMed     Text format     Abstract available


    Cancer Res

  6. ORLANDO D, Miele E, De Angelis B, Guercio M, et al
    Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma.
    Cancer Res. 2018 Apr 3. pii: 0008-5472.CAN-17-3140.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. MARTINEZ-RICARTE F, Mayor R, Martinez-Saez E, Rubio-Perez C, et al
    Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumour DNA from cerebrospinal fluid.
    Clin Cancer Res. 2018 Apr 3. pii: 1078-0432.CCR-17-3800.
    PubMed     Text format     Abstract available


    Eur J Cancer

  8. ALIFRANGIS C, Wilson P, Shamash J
    Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment
    Eur J Cancer. 2018 Mar 31. pii: S0959-8049(18)30226.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  9. YU VY, Landers A, Woods K, Nguyen D, et al
    A Prospective 4pi Radiation Therapy Clinical Study in Recurrent High-Grade Glioma Patients.
    Int J Radiat Oncol Biol Phys. 2018;101:144-151.
    PubMed     Text format     Abstract available


    J Neurooncol

  10. VAN WESTRHENEN A, Senders JT, Martin E, DiRisio AC, et al
    Clinical challenges of glioma and pregnancy: a systematic review.
    J Neurooncol. 2018 Apr 6. pii: 10.1007/s11060-018-2851.
    PubMed     Text format     Abstract available

  11. MILLER SE, Tummers WS, Teraphongphom N, van den Berg NS, et al
    First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
    J Neurooncol. 2018 Apr 6. pii: 10.1007/s11060-018-2854.
    PubMed     Text format     Abstract available

  12. KOTROTSOU A, Elakkad A, Sun J, Thomas GA, et al
    Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
    J Neurooncol. 2018 Apr 4. pii: 10.1007/s11060-018-2850.
    PubMed     Text format     Abstract available


    J Neurosurg

  13. BASHIR A, Brennum J, Broholm H, Law I, et al
    The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[(18)F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    J Neurosurg. 2018 Apr 6:1-14. doi: 10.3171/2017.8.JNS171577.
    PubMed     Text format     Abstract available

  14. CHEN WC, Magill ST, Wu A, Vasudevan HN, et al
    Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    J Neurosurg. 2018 Apr 6:1-8. doi: 10.3171/2017.9.JNS171609.
    PubMed     Text format     Abstract available


    Neuro Oncol

  15. ALEXANDER BM, Cloughesy TF
    Platform trials arrive on time for glioblastoma.
    Neuro Oncol. 2018 Apr 2. pii: 4958219. doi: 10.1093.
    PubMed     Text format    

  16. BABAK S, Mason WP
    mTOR inhibition in glioblastoma: requiem for a dream?
    Neuro Oncol. 2018 Mar 28. pii: 4955983. doi: 10.1093.
    PubMed     Text format    

  17. AKBARI H, Bakas S, Pisapia JM, Nasrallah MP, et al
    In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
    Neuro Oncol. 2018 Mar 30. pii: 4956862. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery


  18. Science Times.
    Neurosurgery. 2017;80:N7-N16.
    PubMed     Text format    

  19. GESSLER F, Bernstock JD, Braczynski A, Lescher S, et al
    Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
    Neurosurgery. 2018 Mar 27. pii: 4955252. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. HALL WA, Pugh SL, Wefel JS, Armstrong TS, et al
    Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
    Neurosurgery. 2018 Mar 30. pii: 4957030. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. SAITO T, Muragaki Y, Shioyama T, Komori T, et al
    Malignancy Index Using Intraoperative Flow Cytometry is a Valuable Prognostic Factor for Glioblastoma Treated With Radiotherapy and Concomitant Temozolomide.
    Neurosurgery. 2018 Mar 30. pii: 4957033. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. UNG TH, Ney DE, Damek D, Rusthoven CG, et al
    The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma.
    Neurosurgery. 2018 Mar 30. pii: 4957035. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS Genet

  23. ARBEILLE E, Bashaw GJ
    Brain Tumor promotes axon growth across the midline through interactions with the microtubule stabilizing protein Apc2.
    PLoS Genet. 2018;14:e1007314.
    PubMed     Text format     Abstract available


    PLoS One

  24. MOREAU J, Khalil T, Dupic G, Chautard E, et al
    Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy.
    PLoS One. 2018;13:e0195608.
    PubMed     Text format     Abstract available

  25. BERLOW NE, Svalina MN, Quist MJ, Settelmeyer TP, et al
    IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
    PLoS One. 2018;13:e0193565.
    PubMed     Text format     Abstract available


    Radiology

  26. PEREZ-BETETA J, Molina-Garcia D, Ortiz-Alhambra JA, Fernandez-Romero A, et al
    Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.
    Radiology. 2018 Apr 3:171051. doi: 10.1148/radiol.201171051.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: